Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.565
-0.030 (-0.65%)
May 18, 2026, 4:18 PM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.43 billion as of May 18, 2026. Its market cap has increased by 8.63% in one year.
Market Cap
1.43B
Enterprise Value
1.73B
Revenue
674.06M
Ranking
n/a
PE Ratio
17.46
Stock Price
€4.57
Market Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.43B, an increase of 774.27%. That is a compound annual growth rate of 6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.43B | -10.95% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.42B |
| Laboratorios Farmaceuticos Rovi | 3.04B |
| Almirall | 2.47B |
| Pharma Mar | 1.69B |
| Clínica Baviera | 884.22M |
| Prim, S.A. | 223.73M |
| Laboratorio Reig Jofre | 218.18M |
| Oryzon Genomics | 218.12M |